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In 1993, the Department of Defense (DoD) implemented an 
inventory reduction program for medical treatment facilities referred to as Prime 
Vendor (PV). This program was a new approach to the procurement and 
management of pharmaceutical and medical/surgical supplies. The results have 
been documented as an overwhelming success. 
Typically, a medical treatment facility's laboratory department has 
the same type of inventory issues as a pharmacy. The products have a predictable 
usage rate and usually a short shelf life, overstocking typically occurs, a 
considerable amount of manpower is applied to maintaining the stock, and 
information technology is not used to expedite order processing. 
This research provides insight into the feasibility and effects of 
implementing a prime vendor program for laboratory supplies and related material. 
The findings show that many of the benefits realized in civilian industry and in the 
Pharmaceutical and Medical/Surgical Prime Vendor Programs can be realized in 
the medical treatment facility's laboratory departments with the creation and 
implementation of a Laboratory Prime Vendor Program. 
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This thesis evaluates the Prime Vendor Program developed by the Defense 
Personnel Support Center (DPSC) and Military Medical Departments. To 
understand the program requires an examination of the overall program structure 
and the differences between the current Pharmacy and Medical/Surgical programs. 
In addition, the examination of Military Medical laboratory departments, their 
systems, data and specific need requirements is necessary in order to identify 
areas that could be improved by implementing a Laboratory Prime Vendor Program. 
B. BACKGROUND 
In 1993, the Department of Defense (DoD) implemented an inventory 
reduction program for medical treatment facilities referred to as Prime Vendor (PV). 
This program was a new approach to the procurement and management of 
pharmaceutical and medical/surgical supplies. The results have been documented 
as an overwhelming success. 
The main goal of the Defense Personnel Support Center (DPSC) in 
instituting the PV program was to reduce each medical treatment facility's overall 
delivered cost for brand name medical supplies by reducing stock levels, reducing 
the losses caused by expired and overstocked goods, reducing manpower, and by 
using existing industry automation to expedite order processing. 
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The intent of this research is to see if the current Prime Vendor Program can 
be enhanced by applying the same goals and lessons learned from this program 
to the medical treatment facility's laboratory departments. 
Typically, laboratories have the same type of inventory issues as a 
pharmacy. The products have a predictable usage rate and usually a short shelf 
life, overstocking typically occurs, a considerable amount of manpower is applied 
to maintaining the stock, and information technology is not used to expedite order 
processing. 
In order to maximize the goals of DPSC, the just-in-time philosophy must be 
adapted in the daily operations of the laboratory. This research provides insight 
into the feasibility and effects of implementing a prime vendor program for 
laboratory supplies and related material. 
C. OBJECTIVE OF THE RESEARCH 
The objective of this study is to provide interested parties in the DoN and 
DoD with an evaluation of the medical prime vendor program's successes and 
concerns and an assessment of implementing a prime vendor program for 
laboratory supplies and related material. 
D. RESEARCH QUESTIONS 
The primary question that this thesis endeavors to answer is: Can 
implementing a prime vendor program for laboratory supplies and related material 
benefit DoD? In addition to answering the primary question, subsidiary research 
questions are addressed: 
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• What is the history of the Prime Vendor Program?- What are the 
fundamentals of the Prime Vendor Program? What type of contracts are 
in place and how are they managed? What are the benefits of the Prime 
Vendor Program? What are the lessons learned from the Pharmaceutical 
and Medical/Surgical Prime Vendor Programs? These questions are 
answered in Chapter II. 
• Who are the key manufacturers and what are their capabilities? Do they 
typically have distribution centers across the country or only regionally? 
Can they handle the business volumes for DoD on a daily basis? What 
are the Electronic Ordering capabilities of the vendors? These questions 
are answered in Chapter Ill. 
• What are the areas of concern with implementing a Laboratory Prime 
Vendor Program? What are the potential benefits to the MTF, laboratory, 
and Defense Personnel Support Center? What are the concerns related 
to the Laboratory Prime Vendor contract? What are the alternatives? 
Should the Prime Vendor contracts be regional or national? -Can 
laboratory items be added to existing medical/surgical or pharmacy 
contracts, or are new contracts necessary? Does training the users play 
a role in the success of the Prime Vendor Program? These questions 
are answered in Chapter IV. 
• Are there any specific considerations to implementing a Prime Vendor 
Program for laboratory supplies and related material? What are the 
recommendations? These questions are answered in Chapter V. 
E. SCOPE AND LIMITATIONS 
This thesis consists of an examination of the Prime Vendor Program as 
currently employed by DPSC and the Military Medical Departments. It examines 
relevant historical and background information; the current systems, data and 
specific calculations used in determination of payment prices; the impact on Military 
Treatment Facilities (MTFs) decisions regarding policy and resources; and 
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alternative approaches. Because of the recent introduction of this concept, this 
thesis is limited to current experience. 
F. LITERATURE REVIEW AND METHODOLOGY 
Publications, instructions, and working papers from DPSC, DLA, 
NAVMEDLOGCOM and various Military Medical Departments were reviewed for 
areas relating to the Prime Vendor Program. This provided background data on 
practices and the implemented programs. 
Key personnel from DPSC, DLA, NAVMEDLOGCOM and various Military 
Medical Treatment Facilities were interviewed to gain additional insight and 
perspectives into the current program. 
G. DEFINITIONS, ABBREVIATIONS, AND ACRONYMS 
Definitions of certain terms presented in the thesis are given as they arise. 
A list of abbreviations and acronyms is presented after the Table of Contents. 
H. ORGANIZATION OF THE THESIS 
The thesis is divided into five parts. The first part is an overview and history 
of the medical Prime Vendor Program, followed by a general analysis of the 
program's successes and concerns in the second part. Then the third part is an 
assessment of commercial vendors for laboratory supplies, and the fourth part 
discusses concerns, concepts, and options. Finally, the fifth part gives 
recommendations for or against the implementation of a laboratory prime vendor. 
4 
I. CHAPTER OUTLINE 
Following the introduction chapter, which provides a general overview ofthe 
concept and current DPSC policy on the Prime Vendor Program, this thesis is 
organized into five chapters: 
• Chapter II provides an overview of the Pharmaceutical and 
Medical/Surgical Prime Vendor Programs and an analysis of successes 
and areas of concern. 
• Chapter Ill examines the commercial vendors of medical laboratory 
supplies. 
• Chapter IV presents the implementation issues relevant to a Laboratory 
Prime Vendor Program. 
• Chapter V presents the recommendations for or against the 
implementation of a Laboratory Prime Vendor Program. 




- II. PRIME VENDOR PROGRAM OVERVIEW 
A. THE HISTORY OF THE PRIME VENDOR PROGRAM 
The current Military Prime Vendor Programs came about as a result of 
General Accounting Office Report No. NSIAD 92-58, "DoD Medical Inventory: 
Reductions Can Be Made Through the Use of Commercial Practices," December, 
1991. Specifically, the report noted that DLA warehouses were overstocked and 
it recommended inventory management initiatives similar to those practiced at 
Vanderbilt University Medical Center and the Veterans Administration. In addition 
to the GAO report, reductions in military and civilian personnel along with 
decreased operating budgets signaled an immediate need for changes to the 
inventory practices used. 
Before Prime Vendor, supplies were provided by the Defense Personnel 
Support Center (DPSC) through standard stock material or local suppliers. This 
created an accumulation of large inventories in order to deal with the lack of timely 
deliveries and uncertainties of availability. Additionally, there were problems with 
expiration of shelf life material, misuse of priorities, and increased open purchases. 
To fix the problems noted by the report, the system had to change. 
Personnel was not the problem, they were doing their jobs right, it was the system 
that was wrong. Medical inventory systems were operating on a "just-in-case" (JIC) 
inventory system in order to adjust to lead times and to protect against stockouts. 
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DoD conducted research to move to emulate commercial business practices. 
One of the first sites where DoD conducted research was at Vanderbilt University 
Medical Center (VUMC). VUMC is a successful example of the "just-in-time" (JIT) 
inventory management system for three major reasons. To begin with, VUMC's JIT 
inventory practices were effective in improving processes that lead to cost savings, 
while improving quality. Next, breaking down the traditional communication barriers 
internally and externally to the organization allowed for new roles to emerge and 
produced mutual benefits for all parties. Lastly, VUMC adopted the JIT philosophy 
and it was embraced by everyone in the organization in their approach to and 
resolution of complex issues. 
After conducting the research, DoD began the Medical Prime Vendor 
Program. It's initiative was to "Buy Response, Not Inventory." The Medical Prime 
Vendor Program became a cooperative venture between the Defense Logistics 
Agency (DLA) and commercial industry. It provided federal medical facilities with 
a consolidated source of supply for brand specific items. The program was 
developed and administered by the Directorate of Medical Materiel of the Defense 
Personnel Support Center (DPSC) in Philadelphia, PA. 
Prime Vendor allowed military treatment facilities to change their JIC 
inventory program to a JIT program through implementation of a combination of the 
JIT philosophy and JIT purchasing techniques. 
B. FUNDAMENTALS OF THE PRIME VENDOR PROGRAM 
DPSC defines a Prime Vendor as a single distributor of commercial "brand-
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specific" supplies from a group of purchasers in a given geographic area. Their 
goal is to provide delivery of products to satisfy ordering facility needs with a just-in-
time system to supply military treatment facilities with deliverable pharmaceutical 
and medical/surgical products of all types (consumable and reusable). 
The major features of the DPSC Medical Prime Vendor Program is that it 
provides: 
• Comprehensive product coverage of pharmaceutical and 
medical/surgical products, 
• Next day delivery, 
• Best overall pricing in the industry, 
• Total geographic coverage, 
• Automated bill payment, 
• Availability of emergency deliveries, and 
• Guaranteed minimum 95 percent fill-rate. 
Previous business practices resulted in clinical personnel spending valuable 
time and money managing supplies in their areas. As a result, Military Treatment 
Facility (MTF) personnel established and maintained unofficial inventories to 
ensure availability of material. Maintaining the unofficial inventories consumes 
supply dollars and degrades the ability of material managers to justify related 
budgets. These unofficial inventories represent unrecorded demand histories, 
which is a key component of the data needed to properly support the prime vendor 
program. 
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Prime Vendor enables MTFs to take advantage of the commercial vendor's 
distribution systems. It allows the MTF to tap into resources that their current 
transportation systems cannot duplicate. It enables the customer access to a 
vendor's inventory and delivery within 24 hours. Prime Vendor bypasses the 
clogged supply pipeline and lays a new streamlined process providing a fresher 
product for the customer. 
The Prime Vendor Program is a contract, between the government and a 
distributor, for one day, automated order processing and delivery of 
Pharmaceuticals and Medical/surgical supplies to medical treatment facilities within 
a geographic region. This re-engineering effort adopted commercial business 
practices and involves implementing buying practices through the use of Electronic 
Data Interchange. The goal has been to improve quality of support to health care 
providers while reducing both wholesale (depot) and retail (MTF) inventories DoD 
wide. 
The United States has been divided into twenty-two regions (see graph on 
the next page), with one prime vendor for pharmaceutical items and one prime 
vendor for medical/surgical items, delivering commercial products to all ordering 
facilities within that region. 
C. CONTRACTS 
The Directorate of Medical Materiel awarded the first pharmaceutical contract 
in January 1993 and the first medical/surgical contract was awarded in June 1993. 
Awards were initially announced covering MTFs in the National Capital region and 
10 
REGION FACILITIES REGION 
1.AUTN/AR 7 12. MONTANA 
2. ALASKA 3 13. NATL CAPITAL 
3. CAROLINAS 14 14. NY/NE 
4. CASCADES 6 15. OH/IL 
5. DAKOTAS 3 16. PACIFIC 
6. EUROPE 16 17. PANHANDLE 
7. FUGA 17 18. ROCKY MTS 
8. HAWAII 3 19. SAN DIEGO 
9. IUKY!MO 4 20. SAN FRANCISCO 
10.LONESTAR 18 21. TIDEWATER 
11.MIDWEST 5 22. UTAH/IDAHO 














purchases from prime vendors began 45 to 11 0 days after the award of each 
contract. 
At the end of FY 1995, 20 pharmaceutical contracts and 6 medical/surgical 
contracts had been awarded. Those 26 contracts represent agreements to 
purchase approximately $908 million annually in pharmaceuticals and 
approximately $114 million annually in medical and surgical items. At the end of 
FY95, 236 MTFs were covered under the pharmaceutical contracts and 44 MTF 
under the medical/surgical contracts. 
D. CAPAs 
As part of the Prime Vendor Program, Distribution and Pricing Agreements 
(DAPAs) were established between DPSC and the pharmaceutical and 
medical/surgical manufacturers and distributors. Under the DAPA, the agreement 
holder consents to allow the prime vendor to distribute its products to the ordering 
facilities and agrees that the prime vendor will be charged the same price as 
established in the agreement. 
DPSC has established the DAPA management system in order to: 
• Increase availability of products, 
• Automate manual application and review process, 
• Increase data integrity, 
• Provide user-friendly access to DAPA database, and 
• Streamline access to DAPA prices for all prime vendors and DAPA 
holders. 
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These DAPAs use Federal Stock System price as a ceiling price unless there 
is no FSS available, in which case uses leveraged pricing strategy. Only products 
that have DAPAs can be ordered from the manufacturer/distributor. This utilization 
allows DoD to increase the speed at which products are made available to the 
ordering facility by re-engineering the DAPA business practice. 
E. BENEFITS OF THE PRIME VENDOR PROGRAM 
The major benefits of the Prime Vendor Program were directly addressed in 
the General Accounting Office Report No. NSIAD 92-58, "DOD Medical Inventory: 
Reductions Can Be Made Through the Use of Commercial Practices," December, 
1991, are General Inventory Reduction, Wholesale Storage Depot Inventory 
Reduction, and Increased Customer Satisfaction. 
1. General Inventory 
Defense Logistics Agency (DLA) wholesale medical inventories have 
decreased since the medical prime vendor program began in 1993. Those 
reductions are attributed to the ability of MTFs to order smaller quantities, more 
frequently, because prime vendors can deliver medical supplies from available 
stock within 24 hours, with emergency deliveries within 6 hours. In addition, losses 
created by the expiration and overstocking of pharmaceuticals have also been 
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Figure 1. Value of Medical Inventory in DoD Wholesale Depot 
2. Wholesale Storage Depot Inventory 
DLA wholesale medical inventories have decreased as a result of various 
inventory reduction initiatives, including the Prime Vendor Program. In January 
1992, medical inventories at DoD storage depots totaled $607 million with $361 
million in medical and surgical items and $246 million in pharmaceutical items. By 
March 1993, those inventories had been reduced as the result of humanitarian 
assistance, disposal action, and other inventory reduction initiatives. After March 
1993, wholesale medical inventories continued to decline, principally as the result 
of the Prime Vendor Program. As shown in Figure 1, wholesale medical inventories 
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have decreased from $333 million in March 1993 to $206 million-in September 
1995. The largest decrease was for the pharmaceutical items which declined from 
$140 million to $49 million. (DOD IG 1996) 
3. Customer Satisfaction 
In surveys conducted by DPSC, customers stated that they were very 
satisfied with the Prime Vendor Program and that most of the desired benefits have 
been achieved particularly in the area of pharmaceuticals. Pharmacists noted 
faster delivery, fewer stock outages, a reduction in administration time, and a 
reduction in inventory. (THOMAS) 
The steady increase in purchases since the beginning of the Prime Vendor 
Program, as shown in Figure 2, is a clear indication of customer satisfaction. 
Figure 2 shows the purchases by month and by fiscal year since March 1993 (DOD 
IG 1996). During the last six months of 1993, purchases from the prime vendors 
totaled $10 million, and then rose dramatically to $170 million in FY1994 and $476 
million in FY 1995. 
Per the 1996 GAO audit, there has been no major failures with this program. 
The largest concern is that the gains made by implementing a Medical/Surgical 
Prime Vendor Program have not mirrored the success of the Pharmaceutical Prime 













Figure 2. Customer Purchases from Prime Vendors 
Sep95 
F. LESSONS LEARNED FROM PHARMACEUTICAL AND 
MEDICAUSURGICAL PRIME VENDOR PROGRAMS 
The Prime Vendor Program has demonstrated that it works and it works well. 
As clearly shown in Figures 1 and 2, both the Pharmaceutical and Medical/Surgical 
Prime Vendor Programs have been successful, but the Pharmaceutical Program 
has been more successful. 
There are several reasons the pharmaceutical program has been more 
successful. First, the pharmacy is an extremely centralized area with one person 
in control. The pharmacist not only counts the inventory and does the ordering, but 
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actually is the person depleting the stock when filling a prescription. This is a good 
example of a perpetual inventory system in action. 
Secondly, pharmacists commonly receive some business training during their 
education and clerkship. Some pharmacists are also involved in civilian pharmacy 
organizations, and may even work with civilian pharmacies. This allows them to be 
exposed to modern business practices, such as JIT and Prime Vendor. 
This familiarity allowed the pharmacists to adopt this program with relative 
ease because they were familiar with the type of process and DPSC included them 
in the process and provided training in the JIT system. In the pharmacy, the 
inventory managers are the pharmacists and by adopting this program, it actually 
made their operation smoother and more efficient in both dollars and time spent in 
their day-to-day activities. This is why the pharmacists were willing to adopt the 
program so easily. 
The Medical/Surgical Prime Vendor Program has demonstrated that it can 
be successful, but its growth rate has been slow, as shown in Figure 2. There are 
seven major differences between the Pharmaceutical and Medical/Surgical Prime 
Vendor Programs that led to the slower adoption rate. 
First, the Medical/Surgical arena is a highly decentralized inventory system 
with each Medical/Surgical area ordering what it needs from material (inventory) 
managers located at the MTF. 
Second, in contrast to the pharmacists, some of the material managers and 
material management personnel have never received training in material 
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management, -much less in modern business practices, such as JIT and Prime 
Vendor. Research interviews were conducted with personnel from DPSC, Material 
Management Department Heads, Financial Department personnel, Laboratory and 
Pharmacy Department Heads and related personnel at National Naval Medical 
Center Bethesda, Walter Reed Army Medical Center, and Naval Hospital 
Portsmouth. These interviews indicate that it is less likely that material managers 
and material management personnel have been involved in civilian material 
management organizations, thus they have had less exposure and training than the 
pharmacists. 
Third, the Prime Vendor Program was implemented in Medical/Surgical 
because of the success in the pharmaceutical arena. Senior leadership failed to 
realize that the dynamics of the Medical/Surgical program were not the same as for 
the Pharmaceutical Prime Vendor Program. Unfortunately, when the 
Medical/Surgical Prime Vendor was implemented, the material management 
personnel, with less exposure, experience, and education, received less training 
and guidance. 
Fourth, the material managers had no incentive to effectively adopt this 
system. The Prime Vendor Program was not "packaged and sold" to them as it was 
to the pharmacists. Many material managers and material management personnel 
saw the Prime Vendor Program as a direct threat to their job security. 
Fifth, the Pharmaceutical Prime Vendor Program had a phased approach 
with each region up and running prior to implementing the next region. When the 
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Medical/Surgical Program was started, the users were not educated nor exposed 
to this new program prior to its implementation. The underlying assumption DPSC 
made was that because the Pharmaceutical Prime Vendor Program was successful, 
the Medical/Surgical Prime Vendor Program would be just as successful, but they 
failed to involve and educate the users in the process. (WOOD) 
Sixth, as with any organizational change, the failure to invest in training and 
educating the workforce in a new program often creates a negative feeling towards 
the new program and slows employee participation and buy-in. This is what 
happened with the Medical/Surgical Prime Vendor Program. The Medical/Surgical 
Prime Vendor Program has been a success, but not of the same magnitude as the 
Pharmaceutical Prime Vendor Program. The lack of planning prior to 
implementation made the transition difficult. (WOOD) 
Seventh, Pharmaceuticals typically use National Drug Codes (NDCs) to 
identify the product. With the use of NDCs, it is relatively easy to identify different 
products. Pharmacists are familiar with the process of identifying products in this 
manner, therefore it was easy for them to adapt to the Prime Vendor process of 
ordering medications. 
In the medical/surgical arena there was no such identification numbers. 
Each manufacturer or distributor has its own method of identifying the product. 
What one company identifies as one product, another may call something 
completely different. Equivalent or even like items are not easily identifiable. This 
required the procurement department to conduct more extensive research of 
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products to identify the correct item to order. It required more effort and more time 
to be spent to identify the correct product and thus, led to a slower adoption rate of 
the Medical/Surgical Prime Vendor Program. 
DPSC has tackled this by creating a Product and Price Comparison Catalog. 
This catalog, available via computer disks, provides the purchasing agent with a list 
of the products available by name, type, manufacturer, etc. Although more time is 
required to create and sometimes use this catalog, it provides the procurement 
official with the resources to identify the correct product to order. 
After the initial two and one half years of the Pharmaceutical and Medical 
Surgical Prime Vendor Programs' existence, Department of Defense Inspector 
General Report No. 96-109, "Audit of Prime Vendor Support of Medical Supplies," 
May 1996, cited only minor errors with the Prime Vendor Program. These errors 
were mainly attributed to using incorrect distribution fees, incomplete catalog data 
(from the DAPAs), and not taking advantage of manufacturer rebates. This final 
area was not addressed in the Prime Vendor Program itself. DoD has little 
experience in dealing with manufacturer's rebates or discounts when buying bulk 
quantities. Currently, some MTFs take rebates, other MTFs take them in the form 
of credit, while still others take them in the form of other qualified contractual items. 
Purchases made with manufacturer rebates are not recorded in the procurement 
system. In all instances, the material is placed in inventory and issued under the 
same procedures as material purchased through the procurement system. (DoD 
IG 1996) 
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G. CHAPTER CONCLUSION 
DLA has successfully implemented a "Buy Response, Not Inventory" 
procurement process that mirrors commercial business practices with its 
implementation and success of the Medical Prime Vendor Program. General 
Accounting Office Report No. NSIAD 95-142 (OSD Case No. 9919), "Inventory 
Management: DoD Can Build Progress in Using Best Practices to Achieve 
Substantial Savings," August 4, 1995, reported that the Prime Vendor Program for 
medical supplies is the most successful program in DoD. 
"The best way to gain support of an idea or program is to demonstrate that 
it works," (FIELDS). Prime Vendor has clearly shown that it works. The success 
of this program provides a benchmark for military organizations to look at to adapt 
similar commercial practices for other consumable items purchased, such as office 
supplies, subsistence, dental supplies, optometry supplies, and laboratory supplies. 
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Ill. ANALYSIS OF COMMERCIAL VENDORS -
A. KEY MANUFACTURERS/DISTRIBUTORS 
Defense Personnel Supply Center (DPSC) provided the authors with the 
names of the five largest suppliers of current prime vendor service under the 
existing pharmaceutical and medical/surgical agreements. The authors conducted 
Interviews with representatives ranging from corporate Vice Presidents to Directors 
of Military/Corporate Accounts. 
B. MANUFACTURER AND/OR DISTRIBUTOR CAPABILITIES 
The five interviewees all agreed that Baxter Healthcare Corporation and 
Fisher Scientific Corporation are the two major companies that could provide a 
prime vendor service in the laboratory area at the present time. The three other 
companies interviewed (Owens & Minor, Durr, and Colonial Healthcare) stated that 
they are not in the laboratory supply business at this time. This is not to say they 
could not acquire the expertise or equipment to do this, but it is currently not one 
of their goals. 
1. Baxter Healthcare Corporation 
Baxter Healthcare Corporation (Baxter) is the largest provider of health care 
supplies. Baxter is both a manufacturer and distributor and is an experienced 
Prime Vendor since Baxter is DoD's Medical/Surgical Prime Vendor for the San 
Diego area. 
23 
Baxter manufactures many laboratory specific products, reagents, and 
capital equipment used in the lab. Baxter recently spun off their distribution 
company on October 1, 1996. Baxter's Hospital Distribution and Laboratory Supply 
Distribution are now integrated into the newly formed Allegiance Corporation. In 
addition to this manufacturing capability their former "Scientific Products" division 
was a market leader (maintained a competitive advantage) in the research 
laboratory products area for a number of years. This portion was recently sold to 
VWR Scientific Products (VWR). 
Allegiance provides thousands of products and services needed by 
hospitals, laboratories and others in health care. As stated above, they 
manufacture many of the products they supply, while others come from leading 
health and medical companies from around the world including Johnson & Johnson, 
3M, Baxter, Dade International, Kendall, Coming, Mallinckrodt, Becton Dickinson, 
Tecnol and Tenneco. Allegiance believes the key is not just providing the product 
but also providing a unique set of innovative, integrated cost management services. 
This is extremely important in health care today because it allows hospitals 
to save money and focus on patient care rather than supplies and logistics. 
2. Fisher Scientific Corporation 
Fisher Scientific Corporation (Fisher Scientific) is also a manufacturer and 
a distributer. Fisher Scientific is currently a DAPA holder, but does not have any 
Prime Vendor experience in the DoD Pharmaceutical or Medical/Surgical Prime 
Vendor Programs. However, they have been awarded two Prime Vendor contracts 
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in support of the more specialized lab research divisions, Armed Forces Institute 
of Pathology (AFIP) and Walter Reed Army Institute of Research (WRAIR). 
Fisher Scientific manufacturers one-third of their chemical products, with the 
other two-thirds comprised via negotiations between Fisher Scientific and the 
manufacturer of the products. Fisher Scientific's concentration is predominantly in 
the industrial, governmental, educational, and research marketplace. They have 
a smaller niche in the clinical marketplace which they just recently entered when 
Fisher Scientific acquired Curtis Mattheson Scientific in October 1995. 
3. Other Suppliers 
VWR was mentioned during our interview with Fisher Scientific director of 
corporate accounts, Dr. Anthony Viscido, but they are purely an industrial 
governmental educational supplier. They do not carry any clinical product line 
which would be required to support DoD's requirements. They could participate in 
a prime vendor program, but for research laboratories only. 
The other aspect that will be recommended as an area for further study is the 
analysis of the small businesses that have shown an interest in participating in a 
laboratory prime vendor program. Small business will not be addressed for the 
remainder of this paper. 
C. DISTRIBUTION CAPABILITY 
Both Allegiance and Fisher Scientific have major national distribution 
centers, not only across the country but internationally as well. Distribution to any 
CONUS DoD facility could be easily facilitated by current distribution network as 
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shown in Appendix A and B. Allegiance maintains its own fleet of trucks while 
Fisher maintains a close working relationship with the United Parcel Service (UPS). 
Baxter's and Fisher Scientific's distribution facilities current locations are displayed 
in Appendix A and B, respectively. As this paper explores the feasibility of 
providing service to the continental United States sites only, our distribution 
diagrams show only the applicable 48 states. 
D. ACCOMMODATION OF DoD'S VOLUME 
Both Allegiance and Fisher Scientific state they could accommodate DoD's 
large volume. There are currently just slightly over 1.5 million personnel on active 
duty today. The United States population is approximately 265.1 million. This 
means that currently the active duty portion of the Department of Defense 
comprises only one half of a percentage point of the current US population. In 
addition, end strength is forecasted to fall to less than one million personnel by the 
year 2000. These numbers reflect the magnitude of DoD's portion in the medical 
sector. Baxter, for instance, is a ten billion dollar per year company (prior to the 
creation of Allegiance Health care). Notwithstanding, prior to the restructuring of the 
company, DoD makes up less than five percent of Baxter's ten billion dollar annual 
business in Fiscal Year 1996. (Williams) 
Allegiance is a distributer of many thousands of medical, surgical and 
laboratory products - enough to fill 80 percent of a typical hospital's supply 
needs. On any given day Allegiance delivers more products than any other 
company in our industry (they are without doubt the largest by an order of 
magnitude). An average day consists of about 900,000 boxes to more than 
6000 locations across the country. 
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DoD's Medical Treatment Facilities make up less than two percent of the 
entire United States hospital population (number of hospitals not number of beds). 
As of June 14, 1996 there were 93 Medical Treatment facilities comprised of 9710 
beds available for active duty personnel in the continental United States. Thirty 
one of these Medical Treatment Facilities (one-third) have 25 or less beds. There 
are over 5200 hospitals in the United States. 
E. ELECTRONIC ORDERING CAPABILITIES 
One of the most important component of all is that of Electronic Data 
Interface (EDI). Without EDI, the Prime Vendor Program would still be only an 
unproven theory. This is because Prime Vendor relies on a just-in-time inventory 
which is transparent in patient care while saving DoD hundreds of million dollars. 
This tremendous cost savings and cost avoidance achieved not because these 
Prime Vendor companies have the capability or distribution networks but because 
they know exactly what is being consumed at each facility everyday via their 
Electronic Order Entry (EOE) or EDI systems and have specified points on when 
to resupply these activities. 
1. DPSC's Requirements 
Prime Vendor contractors must demonstrate the following to meet DPSC's 
existing Prime Vendor requirements: 
• Provide adequate training at each ordering facility to ensure that 
government personnel understand the workings of the proposed EOE 
and EDI system. 
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• Provide the required business documents in ANSI X12 format within 
six months of award. 
• Ensure that ordering facilities will be able to place orders to a single 
contractor order receipt point without having to distinguish between 
divisions. 
• An EOE system with a price and product catalog and can ensure that 
all items for which the ordering facilities have provided usage data 
can be loaded within 60 days of contract award. 
• Electronic confirmation within two hours following transmission of the 
order from the ordering facilities in all cases. 
• Provide adequate "help" procedures in place if a problem is 
encountered by Government personnel when interacting with the 
prime vendor's catalog or EOE system. 
2. Current Status 
Baxter, which is performing as a Prime Vendor in the Medical/Surgical Prime 
Vendor Program, meets the existing Electronic Order Entry System (EOE) and 
Electronic Data Interchange (EDI) capability. 
Fisher Scientific is only performing as a Prime Vendor for research 
laboratories, but they too are performing in accordance with above requirements. 
Figures 3 and 4 on the next two pages provide diagrams of how Fisher 
Scientific's EOEIEDI systems are connected between the Prime Vendor, the MTF, 
the DAPA holders, and DPSC. 
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Item Data Base 
WMIS 
TAM.MIS 
Figure 3. Fisher Scientific's Item Data Base 
F. CHAPTERSUMMARY 
In James Brian Quinn's article in 1985 for the Harvard Business Review 
entitled, "Managing Innovation: Controlled Chaos," he talks about large 
organizations undertaking change and states, 
The probability of error increases exponentially with complexity, while 
the system innovator's control over decisions decreases significantly -
further escalating potential error costs and risks. Such forces inhibit 





Figure 4. Fisher Scientific's Procurement Process 
DoD is at a crossroads; it must choose between two strategies. Will DoD 
continue to try to trim patient care to available resources, or will DoD attempt to 
leverage available resources to reach new levels of increased patient care even as 
available resources drop? (Hamel and Prahalad) 
Both vendors are thoroughly capable of providing DoD military treatment 
facilities with a Prime Vendor program for the laboratory area that mirrors that of 
the Pharmaceutical or Medical/Surgical Programs. These companies have a long 
association providing civilian hospitals the same material required by Military 
Treatment Facilities. They also both have established records as Prime Vendors, 
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they have the· capacity, established distribution networks, and Electronic Data 
interface systems required to do the job. 
J. Michael O'Conner states, 
I am convinced commercial distribution can perform its function quite 
effectively and in return assist the DoD Military Treatment Facilities in 
realizing significant savings and efficiency gains. Eliminating the duplication 
of inventories which currently exists from the supply pipeline alone can take 
millions and perhaps billions out of healthcare delivery costs. The labor 
costs associated can be equally significant as it is believed that for every 
dollar you spend on a product you also spend another dollar to acquire and 
possess the product ... These facts are documented as there are "Big 8" 
accounting firm studies that confirm this. (ANDERSON and ERNST) 
These companies have enormous previous experience in the private sector. 
The challenge of adapting to and interfacing with existing DoD system are not 
insurmountable as both the Pharmaceutical and Medical/Surgical Prime vendor 
Programs have shown. 
The next chapter looks at implementation concerns, concepts and options 
for a Laboratory Prime Vendor Program. 
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IV. IMPLEMENTATION CONCERNS, CONCEPTS AND OPTIONS FOR 
A LABORATORY PRIME VENDOR PROGRAM 
A. INTRODUCTION 
Prior to examining specific recommendations, it is necessary to discuss the 
concerns, concepts, and options in order to determine the best alternatives for 
implementing a Laboratory Prime Vendor Program. 
B. LABORATORY PRIME VENDOR PROGRAM AREAS OF CONCERN 
There are three major hurdles that must be overcome prior to implementing 
a laboratory prime vendor program: non-standard laboratory equipment and 
supplies, unique transportation requirements, and lack of universal product 
identification. 
1. Non-standard Laboratory Equipment and Supplies 
Currently, it is common practice for MTFs to make their own local 
arrangements for equipment with lab suppliers. These agreements include leasing 
major laboratory equipment at low cost and in some cases leasing at no charge. 
These contractual agreements are entered into between the MTF and a company 
with the MTF realizing that only that company's reagents and consumables can be 
used in conjunction with that machine. This practice has caused a proliferation of 
non-standard equipment in each facility. In other words, by visiting two separate 
hospitals (regardless of service affiliation) located in the same geographic area of 
the country, each hospital could have completely different pieces of equipment in 
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the laboratories. These agreements between hospital and suppliers exist because 
for the most part they were extremely cost effective. (SCHMITT) 
One concern is that because of these local arrangements and local purchase 
of lab supplies, DPSC does not have accurate demand data nor a record of 
associated supplies being used to support daily laboratory operations. This 
information is necessary because DPSC must have this data in order to ensure 
required items are contracted by DAPAs and enable the Prime Vendor to fill all 
requirements. Since there is no standard brand of equipment or consumables used 
in every MTF (although each conducts similar tests), DPSC would have to require 
each MTF laboratory provide it with an inventory report that includes every major 
piece of test-based equipment used, its corresponding supplies, and the usage 
data. 
Another concern is the legality of the contracts being negotiated at the MTFs 
for equipment. A common practice in the civilian community is one for the hospital 
to contract for the consumables and the company supplying the consumables to 
give the laboratory the equipment free of charge. This is called a "buy-in." While 
this may be accepted in the civilian community, in the military it violates Title 48, 
Code of Federal Regulations- Federal Acquisition Regulations and SECNAVINST 
4001.2F. 
Ideally the equipment in each MTF would be the same as the next, but 
complete equipment standardization is unlikely and it is not required for this 
program to succeed so long as the required product baseline is established, along 
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with corresponding DAPAs, to enable a Prime Vendor to meet the user's 
requirements. Equipment may not be totally standardized throughout the DoD 
system unless one provider is selected for the entire system, but regional 
standardization is a possibility and could be easily achieved by incorporating a 
phased replacement policy for major equipment into a separate DPSC led 
equipment contract. Equipment cannot be included in the same contract with 
consumables because it has a different expense element. Additionally, equipment 
contracts should be worked through the MTF's procurement office and Biomedical 
Repair Office for risk management. 
Another benefit of standardized equipment is that it allows the teaching 
hospitals to train new technicians on the same equipment they will see in the field 
or at their next duty station. 
2. Unique Transportation Requirements 
The Laboratory Prime Vendor Program contracts need to ensure the prime 
vendor can meet all of the transportation requirements. Reagents are time and 
temperature sensitive and may require refrigeration to ensure correct analysis 
results when utilized. These transportation requirements are similar to those of 
pharmaceuticals. Additionally, laboratory distributors have had to meet these same 
requirements to support their civilian customers. 
3. Lack of Universal Product Identification 
The numbering or identification of each different reagent (batch numbers), 
piece of laboratory equipment, and consumables must also be addressed. Under 
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an initiative spearheaded by former DPSC Prime Vendor Program Manager LCDR 
Mitch Cooper, DoD has led the evolutionary process in pharmaceutical and 
medical/surgical products. The vehicle for identifying the product is the Universal 
Product Number (UPN). July 31, 1996 was the deadline placed on the 
manufacturers for one hundred percent compliance. This effort started in October 
of 1992. Currently ninety five percent of items for pharmaceuticals and 
medical/surgical items have been assigned UPN numbers. Civilian medical hospital 
facilities have joined DoD in driving the manufacturers to identify everything down 
to the smallest unit of issue. This is critical to tracking demand and forecasting 
budgets. There are currently two vehicles for assigning UPNs, the UCC/EAN 
Global Product Identification Standard and the Health Industry Business 
Communications Council (HIBCC) format. Both are in bar coded format which is the 
key in allowing the Prime Vendor Program to drive reorder quantities and capture 
usage data. 
C. POTENTIAL BENEFITS TO THE MTF AND LABORATORY WITH THE 
IMPLEMENTATION OF A LABORATORY PRIME VENDOR PROGRAM 
As previously mentioned, there are many potential benefits for both the MTF 
and the laboratory by implementing a Prime Vendor Program. Specifically, they 
include an increase in cash flow, savings in storage space, decrease in 
procurement workload, improved quality of care, job redesign, and improved 
teamwork throughout the MTF. 
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1. Increase in Cash Flow 
Under the Prime Vendor Program, lead time and variability in lead time will 
decrease, therefore, the MTF can decrease its inventory. This will lead to a 
decrease in expenditures to maintain a larger inventory. 
Both Walter Reed Army Medical Center (WRAMC) and Bethesda National 
Naval Medical Center (Bethesda) were able to reduce significant amounts of 
inventory after the start of the Prime Vendor Programs. Bethesda related a 
reduction from 3,600 line items being carried to only 480, inventory value decrease 
from $2,500,000 to $230,000. WRAMC had an inventory reduction valued at 
$3,500,000. 
2. Savings in Storage Space 
As lead time, lead time variability, and inventory decreases, the facility will 
gain space once used for supply storage. This space could be used for an increase 
in patient care areas or other uses. 
During the first year of the Pharmaceutical and Medical/Surgical Prime 
Vendor Program's inception, WRAMC was able to vacate five buildings and one 
floor of another, for a total amount of 42,106 square feet. This amounted to a 
savings of $364,554 in building costs and $31 ,580 in saved utility costs. Similarly, 
Bethesda vacated three warehouses. 
With the implementation of a Laboratory Prime Vendor, space allocated in 
the clinical laboratory areas for supplies can be decreased, potentially providing for 
increased patient workload or expansion of services for the laboratory or MTF. 
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Laboratory products make up a smaller percentage of · inventory than 
Pharmaceuticals and Medical/Surgical, but the same potential impacts exist. 
3. Decrease in Procurement Workload 
Compared to the Prime Vendor Program, depot orders, blanket purchase 
agreements (BPAs), or open purchase orders for various reagents with various 
distributors incur significantly more of the procurement agents time and effort, and 
thus more procurement costs. Implementing the Prime Vendor Program allows the 
number of depot orders, blanket purchase agreements (BPAs), and open purchase 
orders to decrease, thus saving procurement time, effort, and costs. In addition, 
implementing a Laboratory Prime Vendor Program would incur a procurement cost 
for the entire region once every five years if the follow-on options (initial contract 
with four option years) are exercised. 
For example, Bethesda currently maintains over 1800 BPAs for laboratory 
products. These would be unnecessary with a Laboratory Prime Vendor. 
Another benefit is that it decreases the procurement action lead time (PALT) 
of the procurement department. 
4. Improved Quality of Care 
The Prime Vendor Program will result in a faster, more reliable receipt of 
supplies. This allows MTF personnel, previously frustrated by supply issues, to 
focus their attention on patient care. In addition, loss due to shelf life expiration will 
disappear, ensuring that the specified product for the patient is available upon 
demand. 
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5. Job Redesign 
The authors do not expect, promote or actively seek personnel cuts. If 
positions can be realigned to streamline processes, then they should be 
considered. If personnel can be attrited, then this may be indeed beneficial; 
however, we do not anticipate personnel reductions. Instead, job redesign is the 
key. 
In the MTFs, corpsman typically are assigned the responsibility of managing 
their respective department's supply inventory, including inventory management 
and the replenishment of supplies. 
Since the implementation of the Prime Vendor Program, each of the MTF's 
Material Management Departments visited (WRAMC, Bethesda, Portsmouth) has 
taken the initiative to redesign the jobs of their personnel and have placed their 
supply personnel into clinical spaces. Bethesda has titled their initiative, "Forward 
Deployment" and has redesigned the jobs of 50% of their logisticians and 
reassigned them from managing inventory stock in the warehouse to managing 
inventory within clinical spaces. 
Naval Hospital Portsmouth placed a purchasing agent into the operating 
room full-time. WRAMC reported saving over $504,000 in the Material Division Full-
time equivalent (FTE) personnel reductions. 
By redesigning the assignments, the personnel with the training are 
managing the supplies instead of personnel with little to no training. By doing this, 
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it saves hundreds of clinical corpsman man-hours that are better utilized in the 
provision of direct health care services. 
The Bethesda Laboratory uses 1 0 corpsman to manage their laboratory 
supplies. Implementing a Laboratory Prime Vendor could allow for additional 
logisticians to be assigned into the lab and return some of these technicians back 
to their clinical and technical positions. Even if logisticians couldn't be reassigned 
into the laboratory, with less volume of supply to manage, faster delivery, and a 
reduction in administration time, the laboratory technician would at least spend less 
time managing supplies:and it could be managed by less laboratory personnel. 
6. Improved Interaction and Teamwork Throughout the MTF 
As personnel work toward a J IT system, a more cohesive patient care team 
is highly probable. Since inventory levels will be maintained at a minimum, it will 
require that personnel involved in patient care communicate more frequently. It 
solidifies Material Management's involvement in the healthcare team and it could 
lead to an improved quality of care. 
D. POTENTIAL SAVINGS TO DPSC WITH THE IMPLEMENTATION OFA 
LABORATORY PRIME VENDOR PROGRAM 
As previously noted, DLA wholesale medical inventories have decreased as 
a result of various inventory reduction initiatives, including the Prime Vendor 
Program. Looking at the FSC's and dividing the inventory into two main areas, 
dated and non-dated materials, allowed the analysis of 2031 laboratory related 
records. Non-dated material out-sold dated material approximately 3 to 1, as a 
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percentage of sales, this represented 39% and 13% for non-dated and dated 
material respectively. This was used to allocate the support cost based on the 
percentage of sales and the annual medical logistics support costs. 
These figures apply only to the items in which DPSC Medical MSO supplies. 
Due to the wide variations in the types of labs and there associated specific 
requirements, giving an accurate picture of the total costs associated with running 
a lab would be extremely difficult. 
As far as managing the items that DPSC supports, there is no difference in 
the costs, because of the way DoD allocated expenses. Since DoD uses an 
average to allocate costs, there is no opportunity to specifically designate a 
percentage to certain items or FSCs. The only exception that may have an impact 
is the potential disposal costs to remove out-dated materials. 
Since the implementation of the Pharmaceutical and Medical/Surgical Prime 
Vendor Programs, DPSC has been able to reduce the value of their inventory by 
34.92% to $228.5 million. Using this as a basis, a calculated savings for lab 
support items was calculated. It consists of two parts, an actual reduction of 
inventory plus a reduction in the processing fees associated with handling the 
inventory. This comes to an estimated total savings of $2.25 million. Table 1 



















Table 1. DPSC Calculated Savings for Laboratory Support Items 
E. CONTRACTING CONCERNS AND OPTIONS 
The development of a Prime Vendor Program provides the that the distributor 
deliver supplies more often and in smaller quantities. The advantage for the MTF 
is that the distributor will take on the responsibility for storage and transportation. 
The MTF will pay for these services likely in a higher unit cost, however it provides 
long run cost savings that offset the higher unit cost. 
Additionally, the Prime Vendor Program establishes a close relationship with 
select suppliers which is consistent to point four of W. Edwards Demings 14 points 
of management. Point 4 states, "End the practice of awarding business on price tag 
alone." This requires seeking the best quality and work to achieve it with a single 
supplier for any one item in a long-term relationship. 
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A Laboratory Prime Vendor Program will require contracts to be tailored to 
meet the unique requirements of individual/regional MTFs. This is appropriate to 
a JIT system and supports the Total Quality Leadership goals of the USN. 
1. Concerns 
A concern in the contract negotiation and development may be the current 
contracts that MTFs have with their current laboratory equipment and supply 
vendor. The Prime Vendor for each region needs to be able to supply a significant 
amount of supplies to the MTF for it to be profitable. So long as proper usage data 
is collected prior to contract negotiations, DAPA contracts should be able to resolve 
this. Ideally, the MTF's would be uniform in their use of equipment and supplies, 
thus providing a simpler process from both the user and supplier. 
As previously mentioned, DoD regulations require the procurement office to 
buy the laboratory equipment. This is a concern because this will require effective 
communication and coordination between the Laboratory, Prime Vendor and 
Biomedical Repair Division. 
One additional concern is who provides the hardware and software? When 
the Pharmaceutical Prime Vendor Program was implemented, the vendor provided 
the hardware and software. In contrast, when the Medical/Surgical Prime Vendor 
Program was started, the customer had to provide them, and some did not have the 
hardware available. (Libby) 
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2. Contract Alternatives 
There are several alternatives for inventory management that our research 
uncovered. The alternatives consist of continuing with the status quo, adding the 
laboratory products into the Pharmaceutical/Medical Surgical Prime Vendor 
Programs, and the option of choosing a national or regional prime vendor contract. 
a. Status Quo 
By maintaining status quo, this leaves managing laboratory inventory 
to typically the hospital corpsman trained as laboratory technicians. Some are 
better than others, but few typically have training in inventory and procurement 
management. Additionally, in light of budgat forecasts of continuing declines in 
funding, status quo is unacceptable. 
b. Incorporating the Laboratory Products into the 
Pharmaceutical and/or Medical Surgical Prime Vendor 
Programs 
Some products can be purchased through the established Pharmacy 
or Medical/Surgical Prime Vendor Programs, such as some slides, specimen cups, 
etc. However because of the associated specific requirements, only a few generic 
items can be purchased in this manner, so this is not a viable option. 
c. National or Regional Prime Vendor Contract 
The next option is creating one national prime vendor contract or 
several regional contracts. One prime vendor for the continental U.S.( although 
overseas options have not been explored in this research, it is feasible that the 
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program could be expanded to overseas MTFs) could potentially aHow for standard 
equipment to be used throughout DoD. As suggested earlier, the initial 
development of a Laboratory Prime Vendor will require contracts to be tailored to 
meet the unique requirements of individual MTFs. This will take into account the 
laboratory's supplies and materials unique transportation requirements, different 
control numbers/batch lots, refrigeration requirements, hazardous material handling 
and requirements, and vendor percentages. 
F. TRAINING 
It is important to realize that the dynamics of the Laboratory program are not 
identical to either the Pharmaceutical and Medical/Surgical Prime Vendor Program 
and as previously noted, one of the lapses in the Medical/Surgical Prime Vendor 
Program was the lack of education and training for the users. 
When the Medical/Surgical Prime Vendor was implemented, the material 
management personnel received little training and guidance. Some material 
managers and material management personnel have never received training in 
material management, much less modern business practices, such as JIT and 
Prime Vendor. 
To succeed in implementing a Laboratory Prime Vendor Program training 
and retraining will be necessary. The process must involve the user (the laboratory 
staff and MTF's procurement officials). 
The comparison between how the Pharmaceutical and Medical/Surgical 
Prime Vendor Programs were planned and implemented provided a lesson of how 
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to and how not to implement the Laboratory Prime Vendor- Program. The 
Laboratory Prime Vendor Program should have a phased approach, one region up 
and running prior to implementing the next region. The Laboratory Prime Vendor 
Program should be "packaged and sold" to the users. It cannot be viewed as a 
threat to anyone's job security or it will not provide the user with an incentive for the 
program to succeed. 
As with any organizational change, the failure to invest in training and 
educating the workforce in the new program often creates a negative feeling 
towards the new program and slows employee participation and buy-in. 
G. SUMMARY 
Many of the benefits realized in the civilian industry and in the 
Pharmaceutical and Medical/Surgical Prime Vendor Programs can be realized in 
the MTF laboratory departments, with the creation and implementation of a 
Laboratory Prime Vendor Program. The next chapter provides recommendations 
to resolve the concerns in implementing a Laboratory Prime Vendor Program. 
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V. SUMMARY, CONCLUSIONS AND RECOMMENDATIONS 
A. SUMMARY 
The focus of this research was to examine wether or not implementing a 
Prime Vendor Program for laboratory supplies and related material could benefit 
DoD. In order to make that assessment, the following subsidiary questions were 
addressed: 
1. What is the history of the Prime Vendor Program? What are the 
fundamentals of the Prime Vendor Program? What type of contracts are in place 
and how are they managed? What are the benefits of the Prime Vendor Program? 
What are the lessons learned from the Pharmaceutical and Medical/Surgical Prime 
Vendor Programs? 
2. Who are the key manufacturers and what are their capabilities? Do 
they typically have distribution centers across the country or only regionally? Can 
they handle the business volumes for DoD on a daily basis? What are the 
Electronic Ordering capabilities of the vendors? 
3. What are the areas of concern with implementing a Laboratory Prime 
Vendor Program? What are the potential benefits to the MTF, laboratory, and 
Defense Personnel Support Center? What are the alternatives? Should the 
Prime Vendor contracts be regional or national? Can laboratory items be added to 
existing medical/surgical or pharmacy contracts, or are new contracts necessary? 
Does training the users play a role in the success of a Prime Vendor Program? 
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4. Are there any specific considerations to implementing a Prime Vendor 
Program for laboratory supplies and related material? What are the 
recommendations? 
B. CONCLUSIONS 
The findings of this research show that many of the benefits realized in 
civilian industry and in the Pharmaceutical and Medical/Surgical Prime Vendor 
Programs can be realized in the MTF laboratory departments with the creation and 
implementation of a Laboratory Prime Vendor Program. Additionally: 
• A just-in-time program is a long term initiative. 
• The JIT philosophy can be successfully adapted to the healthcare 
industry through the Prime Vendor Program 
• The Prime Vendor Program can be adopted by the MTF Laboratory 
Departments and can be enhanced by applying the same goals and 
lessons learned from the Pharmaceutical and Medical/Surgical Prime 
Vendor Program. 
C. RECOMMENDATIONS 
Based on the findings and conclusions of this research, the Laboratory Prime 
Vendor Program is following a natural course of evolution. The Laboratory Prime 
Vendor Program will work if the following six actions are effectively implemented 
and managed: 
1. Collect Accurate Usage Data 
At the Defense Personnel Support Center (DPSC) level, DPSC should have 
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each MTF laboratory provide it with an inventory report that includes every major 
piece of test-based equipment used, its corresponding supplies, and the usage data 
in order to create effective DAPAs. 
2. Involve the Right People in the Creation of the Statement of Work 
The requirements portion of the Statement of Work should be drawn up with 
the assistance of logisticians and laboratory personnel. Their inputs are invaluable 
because they possess fundamental knowledge from working with these materials 
on a daily basis and can provide a baseline, thus ensuring the contractual 
requirements fulfill the MTFs needs. 
3. Tailor Contracts 
Development of a Laboratory Prime Vendor will require contracts to be 
tailored to meet the unique requirements of individual/regional MTFs. This is 
appropriate to a JIT system. 
The contract should be established to allow the prime vendor to install its 
own equipment and stock its own supplies, thus creating a productive relationship 
between the prime vendor and the customer. Additionally, by forming this 
relationship DoD would receive a better quality product and a better price. As W. 
Edwards Deming states, 
Purchasing departments customarily operate on orders to seek the 
lowest-price vendor. Frequently this leads to supplies of low quality. 
Instead, they should seek the best quality and work to achieve it with a 
single supplier for any one item in a long term relationship... The suppliers 
that serve one company also serve other companies, and will deliver to all 
of them better and better quality with better and better economy. Everybody 
will come out ahead. 
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4. Phased-in Approach 
The Laboratory Prime Vendor Program should be phased in with one region 
up and running prior to implementing the next region. By using this approach, 
follow on regions will start higher on the learning curve and have the ability to avoid 
the difficulties that occurred during the previous region's implementation. A working 
group should be developed to determine the best regions and sites to phase in the 
program. 
5. Conduct Effective Training 
Senior leadership must realize that the dynamics of the Laboratory Prime 
Vendor are not the same as either the Pharmaceutical or the Medical/Surgical 
Prime Vendor Program. Based on the lessons learned in the Medical and Surgical 
Prime Vendor Program, the Laboratory Prime Vendor Program should be 
"packaged and sold" to the users, as it was with the Pharmacy Prime Vendor 
Program and the pharmacists. As with any endeavor in a successful organization, 
DoD must invest in training and educating the workforce so that they will be 
motivated to implement this program. 
At the MTF level, the Director for Logistics/Department Head of Laboratory 
Services must be trained, educated and committed to the program. Additionally, a 
program should be initiated to ensure the education of the Commanding and 
Executive Officers at each MTF on JIT and the Prime Vendor Program. 
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6. Standardize Equipment 
Ideally, the MTFs would be uniform in their use of equipment and supplies, 
thus providing a simpler process from both the user and supplier. It allows the user 
and vendor to establish a rapport, which is conducive to effective business 
interactions and the Navy's TQL program. 
Ideally the equipment in each MTF would be the same as the next, but 
complete equipment standardization is unlikely and it is not required for this 
program to succeed so long as the required product baseline is established, along 
with corresponding DAPAs, to enable a Prime Vendor to meet the user's 
requirements. Equipment may not be totally standardized throughout the DoD 
system unless one provider is selected for the entire system, but regional 
standardization is a possibility and could be easily achieved by incorporating a 
phased replacement policy for major equipment into a separate DPSC led 
equipment contract. Equipment cannot be included in the same contract with 
consumables because it has a different expense element. Additionally, equipment 
contracts should be worked through the MTF's procurement office and Biomedical 
Repair Office for risk management. 
Another benefit of standardized equipment is that it allows the teaching 
hospitals to train new technicians on the same equipment they will see in the field 
or at their next duty station. 
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D. AREAS FOR FURTHER RESEARCH 
This research uncovered several areas that impacted upon Laboratory Prime 
Vendor Program methodology that warrant further research: 
• An analysis of the impact that a Laboratory Prime Vendor may 
have on readiness; 
• A study of additional areas that could benefit from a prime vendor 
program, such as optometry, dental, etc; and 
• A study of the cost savings and cost avoidance realized during the 
first region's activation to validate the full benefit of the Laboratory 
Prime Vendor Program. 
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APPENDIX A. 
ALLEGIANCE DISTRIBUTION FACILITIES (ACTIVE SITES) 
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